Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for ORINF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 60.81%
December 31, 2025 73.16%
September 30, 2025 60.02%
June 30, 2025 59.67%
March 31, 2025 56.98%
December 31, 2024 61.53%
September 30, 2024 67.80%
June 30, 2024 57.54%
March 31, 2024 55.33%
December 31, 2023 55.06%
September 30, 2023 56.92%
June 30, 2023 52.96%
March 31, 2023 56.50%
December 31, 2022 52.70%
September 30, 2022 72.33%
June 30, 2022 61.16%
March 31, 2022 60.79%
December 31, 2021 55.55%
September 30, 2021 54.21%
June 30, 2021 60.93%
March 31, 2021 57.31%
December 31, 2020 54.74%
September 30, 2020 58.01%
June 30, 2020 65.30%
March 31, 2020 62.56%
Date Value
December 31, 2019 58.83%
September 30, 2019 62.43%
June 30, 2019 59.67%
March 31, 2019 59.92%
December 31, 2018 61.43%
September 30, 2018 55.28%
June 30, 2018 63.47%
March 31, 2018 60.52%
December 31, 2017 60.51%
September 30, 2017 53.62%
June 30, 2017 60.53%
March 31, 2017 63.20%
December 31, 2016 59.56%
September 30, 2016 58.66%
June 30, 2016 63.60%
March 31, 2016 60.99%
December 31, 2015 52.10%
September 30, 2015 55.96%
June 30, 2015 62.94%
March 31, 2015 64.83%
December 31, 2014 58.40%
September 30, 2014 57.95%
June 30, 2014 64.04%
March 31, 2014 60.90%
December 31, 2013 60.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 76.09%
ANI Pharmaceuticals, Inc. 51.78%
Corcept Therapeutics, Inc. 98.25%
Assertio Holdings, Inc. 13.91%
Veru, Inc. --

Gross Profit Margin (Quarterly) Related Metrics